Advertisement

Topics

Commonwealth Biotechnologies Inc. (CBI) Company Profile

09:56 EST 18th December 2018 | BioPortfolio

Commonwealth Biotechnologies Inc. (CBI) seeks a QA/QC TECHNICIAN and a LAB AIDE. The successful candidates will receive on-the-job training. The QA/QC Technician supports the general QA efforts of the Company and will assist in instrument calibration, record keeping, and internal audits. The Lab Aide supports general lab operations, including shipping and receiving, handling of hazardous waste materials, maintenance of chemical, solvent, laboratory gas, and general stores inventories, and routine building maintenance. The QA/QC Technician will hold a minimum of a Bachelor’s while a high school diploma is required for the Lab Aide position

Location

601 Biotech Drive
Richmond
Virginia
23235
United States of America

Contact

Phone: (804) 648-3820
Fax: (804) 648-2641
Email: hr@cbi-biotech.com.


News Articles [158 Associated News Articles listed on BioPortfolio]

DGAP-Stimmrechte: Elanix Biotechnologies AG (deutsch)

Elanix Biotechnologies AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Stimmrechtsmitteilung: Elanix Biotechnologies AG Elanix Biotechnologies AG: Veröf...

DGAP-Gesamtstimmrechtsmitteilung: Elanix Biotechnologies AG (deutsch)

Elanix Biotechnologies AG: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Gesamtstimmrechtsmitteilung: Elanix Biotechnologies AG / Ve.....

Deals this week: SQZ Biotechnologies, Immugenyx, Berkeley Lights

SQZ Biotechnologies has expanded its collaboration with Roche to develop products for oncology indications using cellular therapy. The two companies...Read More... The post Deals this week: SQZ Biotec...

DGAP-Adhoc: Elanix Biotechnologies AG: Widerruf der Bestellung von Herrn Tomas J. Svoboda (CEO) als Vorstandsmitglied (deutsch)

Elanix Biotechnologies AG: Widerruf der Bestellung von Herrn Tomas J. Svoboda (CEO) als Vorstandsmitglied DGAP-Ad-hoc: Elanix Biotechnologies AG / Schlagwort(e): Personalie Elanix Biotechnologies A...

DGAP-Adhoc: Elanix Biotechnologies AG: Frau Professor Laurent-Applegate, Gründerin und Interims-Vorstand, kündigt Verkauf von Aktien der Elanix Biotechnologies AG an (deutsch)

Elanix Biotechnologies AG: Frau Professor Laurent-Applegate, Gründerin und Interims-Vorstand, kündigt Verkauf von Aktien der Elanix Biotechnologies AG an DGAP-Ad-hoc: Elanix Biotechnologies AG / Sc....

INVITROGEN MOTHER E-BASE BY ETHROG BIOTECHNOLOGIES

$35.00End Date: Friday Aug-3-2018 5:25:47 PDTBuy It Now for only: $35.00Buy It Now | Add to watch list Biotech365 : INVITROGEN MOTHER E-BASE BY ETHROG BIOTECHNOLOGIES BioMarketplace You want to p...

Elanix Biotechnologies: Erfolgreiche Finanzierungsrunde

Ende Mai hat Elanix Biotechnologies eine Kapitalerhöhung angekündigt, heute kommt die Vollzugsmeldung der Berliner. Die Gesellschaft hat fast 0,68 Millionen Aktien ausgegeben. Der Bezugspreis je Ak....

Commonwealth Hotels Names Director of Sales for the Cincinnati Riverfront, Best Western Plus, ...

COVINGTON, Ky., Nov. 27, 2018 /PRNewswire/ -- Commonwealth Hotels LLC announces the promotion of Molly Fruin to the position of Director of Sales for the Read more...

Drugs and Medications [0 Results]

None

PubMed Articles [32 Associated PubMed Articles listed on BioPortfolio]

Commonwealth Fund Tracks U.S. Health Care Trends.

Four million lose health coverage and many low-income adults now lack insurance.

Kansas and Medicaid: New Evidence on Potential Expansion and Work Requirements.

Kansas remains one of 17 states that have not expanded Medicaid. In 2017, the Kansas legislature voted to expand Medicaid, but former Governor Sam Brownback vetoed the measure.

Biological sulfur oxidation in wastewater treatment: A review of emerging opportunities.

Sulfide prevails in both industrial and municipal waste streams and is one of the most troublesome issues with waste handling. Various technologies and strategies have been developed and used to deal ...

Competition and Premium Costs in Single-Insurer Marketplaces: A Study of Five Rural States.

In 2017, five states--Alabama, Alaska, Oklahoma, South Carolina, and Wyoming--had only one issuer participating in their health care marketplaces, limiting consumer choice and competition among insure...

High-throughput optimisation of light-driven microalgae biotechnologies.

Microalgae biotechnologies are rapidly developing into new commercial settings. Several high value products already exist on the market, and systems development is focused on cost reduction to open up...

Clinical Trials [9 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Health and Economic Consequences of Kentucky's Section 1115 Demonstration Waiver

Kentucky HEALTH is an 1115 Medicaid waiver that was approved by the Centers for Medicare and Medicaid Services (CMS) in January 2018. This 5-year demonstration waiver aims to modify the tr...

Dose and Response of Intrathecal Hydromorphone in Patients Undergoing Cesarean Section at Virginia Commonwealth University Health System

In the United States the incidence of cesarean deliveries have increased over the last several decades and is currently approximately 30% nationwide. The anesthesia and analgesia for elect...

Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal

The investigators are trying to determine whether they can effectively treat patients suffering from acute opioid withdrawal in the Emergency Department at Virginia Commonwealth University...

Aztreonam Aerosol to Treat Cystic Fibrosis Nasal Disease

This study is designed as a masked, two center, randomized, placebo-controlled pilot study to evaluate the safety and efficacy of nasal and oral inhalation of 75 mg aztreonam in subjects w...

Building Wealth and Health Network: A Microfinance/TANF Demonstration Project

The goals of the The Building Wealth and Health Network (The Network) are to develop and rigorously test an asset building model that will build financial, social and human capital through...

Companies [152 Associated Companies listed on BioPortfolio]

Commonwealth Biotechnologies Incorporated

Commonwealth Biotechnologies, Inc. (CBI) is a Contract Research Organization offering a complete array of the most current analytical and synthetic chemistries and biophysical technologies. Their bro...

Commonwealth Biotechnologies Inc. (CBI)

Commonwealth Biotechnologies Inc. (CBI) seeks a QA/QC TECHNICIAN and a LAB AIDE. The successful candidates will receive on-the-job training. The QA/QC Technician supports the general QA efforts of the...

Commonwealth Biotechnologies, Inc.

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc., www.ranbiotechnologies.com, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

Commonwealth Informatics

Commonwealth Informatics is a leader in global cloud-based clinical and safety analytics products and services. Committed to innovation and transforming the process of anal...

More Information about "Commonwealth Biotechnologies Inc. (CBI)" on BioPortfolio

We have published hundreds of Commonwealth Biotechnologies Inc. (CBI) news stories on BioPortfolio along with dozens of Commonwealth Biotechnologies Inc. (CBI) Clinical Trials and PubMed Articles about Commonwealth Biotechnologies Inc. (CBI) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Commonwealth Biotechnologies Inc. (CBI) Companies in our database. You can also find out about relevant Commonwealth Biotechnologies Inc. (CBI) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record